Our partner industries

Advancing Antibody Drug Conjugates to the next generation

LinXis enables you to fully exploit your antibody library.

For BioPharma

Lx® links to native antibodies, without the need for any modification.

Lx® offers affordable, fast and aqueous linking.

Read more

With the LinXis Lx platform you can serve all your clients.

For CMOs

Linking with Lx® does not affect antibody or payload function.

The Lx® platform ensures robust conjugation.

Read more

Partnering with LinXis reduces time to market.

For Pharma

Lx® allows for targeting of low level antigen expressing tumors.

Lx®-based ADCs enlarge the therapeutic window.

Read more